RenovoRx
RenovoRx is a developing innovative solutions for targeted delivery of fluids, including diagnostic and therapeutic agents, to selected sites in the peripheral vascular system. RenovoRx received FDA clearance for the RenovoCath™ RC120 and is currently introducing this innovative technology to the clinical market. RenovoRx has a motivated Management Team with broad experience and an exciting vision for the future of targeted delivery. The company also has a broad Advisory Board of interventional radiologists, surgical oncologists and gastroenterologists that guide the company's clinical development strategies. RenovoRx is backed by a strong Board of Directors committed to long-term, continuous support of the company, whose members provide critical expertise in the medical and biotechnology industry and the visionary thinking to succeed.
Domain
renovorx.com
Country
United StatesIndustry
BiotechnologyEmployees
1-10
Last Funding
$12.1M
Founded
2008
Tech Stack (19 technologies)
Frequently Asked Questions
What technologies does RenovoRx use?+
RenovoRx uses 19 technologies including RSS, Yoast SEO, wpBakery.
What industry is RenovoRx in?+
RenovoRx operates in the Biotechnology industry.
Where is RenovoRx based?+
RenovoRx is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026